| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.52 | 0.002 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |